<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 23, 2000
EMERGENCY FILTRATION PRODUCTS, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Nevada 0-27421 87-0561647
- ----------------- ------------ -------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
4334 South Industrial Road, Suite 440
Las Vegas, Nevada 89103
- -------------------------------------------------------------------------------
(Address of principal executive offices)
(702) 798-4541
- -------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
N/A
- -------------------------------------------------------------------------------
(Former Address of Registrant)
<PAGE> 2
Item 5. Other Events
The Company and third parties have made certain incorrect statements
concerning the business and operations of the Company which may include
projections, forecasts and opinions. The incorrect statements and the correct
information is as follows:
1 - On August 2. 1999, the Company issued a News Release which stated
Human Medical Options International's meeting of its ". . . first year sales
requirements of 320,000 units is a certain reality." This statement has proven
to be incorrect to date. To date, approximately 1,000 units have been sold.
2 - In a News Release dated May 10, 1999 ClubMedic Co-Founder, Mr. Charles
Kirk was quoted as saying, " We expect this to be the first in a continuing
string of orders that will total approximately 20,000 units within 60 days. We
believe that our original estimates of a 40,000 unit per month average volume
after a two month mobilization period is quite attainable and likely." This
statement has proven to be incorrect to date. To date, approximately 3,500 units
have been sold.
3 - In a News Release dated August 19, 1998, it was stated that Preferred
Health Technologies, Inc., was ". . . arranging an equity investment of $500,000
in EMFP." The investment was later made by individuals associated with Preferred
Health, rather than Preferred Health as a company.
4 - On April 20, 1999 Mr. Charles Kirk of ClubMedic said, "We
conservatively estimate the combined market for EFP's current and future
applications to be well over $20 billion USD. This statement is made on Charles
Kirk's own personal basis and no independent evidence supports this statement.
5 - On January 16,1999 the Company announced an association with the
World CPR Foundation (WCPRF). There is no written agreement with the WCPRF and
they are under no obligation to EFP on any matter.
6 - On July 6, 1998 the Company announced the signing of a distribution
agreement with ProMedix, Inc. Because of poor sales performance, both parties
agreed to terminate terms of the agreement in December of 1998.
The Company has released the information contained herein in a news release.
<PAGE> 3
Item 7. Financial Statements and Exhibits
1. Press Release of February 23, 2000
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
EMERGENCY FILTRATION PRODUCTS, INC.
(Registrant)
DATED: February 23, 2000 /s/ MICHAEL CRNKOVICH
-----------------------------------
Michael Crnkovich,
President
<PAGE> 1
EXHIBIT 99.1
EMERGENCY FILTRATION PRODUCTS, INC.
NEWS RELEASE
_______________________________________________________________________________
EMERGENCY FILTRATION PRODUCTS, INC.
ISSUES CORRECTIONS AND CLARIFICATIONS
LAS VEGAS, NEVADA, FEBRUARY 23, 2000 - Emergency Filtration Products, Inc.
("EFP" or "the Company" National Quotation Bureau: EMFP) currently is amending
its pending Form 10SB Registration Statement filed under the Securities Exchange
Act of 1934 with the Securities and Exchange Commission. Michael J. Crnkovich,
EFP's President and Chief Executive Officer, further announced that the Company
will be filing an additional Form 8-K which addresses certain prior incorrect
disclosures.
The Company and third parties have made certain incorrect statements
concerning the business and operations of the Company which may include
projections, forecasts and opinions. The incorrect statements and the correct
information is as follows:
1 - On August 2. 1999, the Company issued a News Release which stated
Human Medical Options International's meeting of its ". . . first year sales
requirements of 320,000 units is a certain reality." This statement has proven
to be incorrect to date. To date, approximately 1,000 units have been sold.
2 - In a News Release dated May 10, 1999 ClubMedic Co-Founder, Mr. Charles
Kirk was quoted as saying, " We expect this to be the first in a continuing
string of orders that will total approximately 20,000 units within 60 days. We
believe that our original estimates of a 40,000 unit per month average volume
after a two month mobilization period is quite attainable and likely." This
statement has proven to be incorrect to date. To date, approximately 3,500 units
have been sold.
3 - In a News Release dated August 19, 1998, it was stated that Preferred
Health Technologies, Inc., was ". . . arranging an equity investment of $500,000
in EMFP." The investment was later made by individuals associated with Preferred
Health, rather than Preferred Health as a company.
4 - On April 20, 1999 Mr. Charles Kirk of ClubMedic said, "We
conservatively estimate the combined market for EFP's current and future
applications to be well over $20 billion USD. This statement is made on Charles
Kirk's own personal basis and no independent evidence supports this statement.
5 - On January 16,1999 the Company announced an association with the
World CPR Foundation (WCPRF). There is no written agreement with the WCPRF and
they are under no obligation to EFP on any matter.
6 - On July 6, 1998 the Company announced the signing of a distribution
agreement with ProMedix, Inc. Because of poor sales performance, both parties
agreed to terminate terms of the agreement in December of 1998.
For further information on the Company, see its web site at
http://www.respaide.com, or contact Sterling Petersen
Phone 800-380-7669
Fax 702-798-4939
Email [email protected]
